drugset / Trial / NCT04158778

Bristol Imperial MDMA in Alcoholism Study

NCT04158778 ↗

Phase 1 Unknown 20 enrolled Imperial College London
NaSingle-groupOpen-labelTreatment

Summary

The Safety, Tolerability and Role of MDMA-Assisted Psychotherapy for the treatment of detoxified patients with Alcohol Use Disorder.

Timeline

Start
2018-04-18
Primary completion
2020-06-12
Completion
2020-06-12

Drugs

EvaluationDrugModalityDoseRoute
Subject MDMA Unknown 125 mg —